高剂量三氟拉嗪治疗慢性精神分裂症 - Suppr

Suppr

超能文献

High dose trifluoperazine therapy in chronic schizophrenia.

作者信息

Prien R F, Levine J, Cole J O

出版信息

Am J Psychiatry. 1969 Sep;126(3):305-13. doi: 10.1176/ajp.126.3.305.

DOI:10.1176/ajp.126.3.305

PMID:4895559

Abstract

摘要

相似文献

High dose trifluoperazine therapy in chronic schizophrenia.高剂量三氟拉嗪治疗慢性精神分裂症

Am J Psychiatry. 1969 Sep;126(3):305-13. doi: 10.1176/ajp.126.3.305.

Selective drug action related to chronic schizophrenic subtype. (A comparative study of carphenazine, chlorpromazine, and trifluoperazine).

Dis Nerv Syst. 1967 Sep;28(9):601-5.

Indications for high dose chlorpromazine therapy in chronic schizophrenia.慢性精神分裂症中高剂量氯丙嗪治疗的适应症。

Dis Nerv Syst. 1970 Nov;31(11):739-45.

Clinical effects of various schedules of medication.

Behav Neuropsychiatry. 1971 Apr-May;3(1):5-9.

A double blind comparison of thiothixene and a trifluoperazine/chlorpromazine composite in the treatment of chronic schizophrenia.硫代噻吨与三氟拉嗪/氯丙嗪复合物治疗慢性精神分裂症的双盲比较

N Z Med J. 1979 Apr 25;89(634):302-4.

Comparison of dosage ranges of carphenazine and trifluoperazine in elderly chronic schizophrenics.

Dis Nerv Syst. 1968 Oct;29(10):695-7.

Neuroleptic therapy for chronic schizophrenia.

Dis Nerv Syst. 1972 Jan;33(1):35-9.

A double-blind comparison of once-a-day pimozide, trifluoperazine, and placebo in the maintenance care of chronic schizophrenic outpatients.

Curr Ther Res Clin Exp. 1974 Jul;16(7):696-705.

The effects of carphenazine, trifluoperazine and chlorpromazine on ward behavior, physiological functioning and psychological test scores in chronic schizophrenic patients.

J Nerv Ment Dis. 1967 Feb;144(2):111-6. doi: 10.1097/00005053-196702000-00004.

High doses of trifluperazine and tardive dyskinesia.

Arch Neurol. 1970 Feb;22(2):176-80. doi: 10.1001/archneur.1970.00480200082009.

引用本文的文献

Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants.用于精神分裂症谱系障碍复发预防的口服长效抗精神病药物：一项纳入92项随机试验（共22,645名参与者）的网状Meta分析

World Psychiatry. 2022 Jun;21(2):295-307. doi: 10.1002/wps.20972.

Maintenance treatment with antipsychotic drugs for schizophrenia.精神分裂症的抗精神病药物维持治疗。

Cochrane Database Syst Rev. 2020 Aug 11;8(8):CD008016. doi: 10.1002/14651858.CD008016.pub3.

The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.在病情稳定的精神分裂症患者中使用持续治疗与安慰剂或间歇治疗策略：对使用第一代和第二代抗精神病药物的随机对照试验的系统评价和荟萃分析

CNS Drugs. 2015 Aug;29(8):637-58. doi: 10.1007/s40263-015-0269-4.

Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia.三氟拉嗪与低效价第一代抗精神病药物治疗精神分裂症的比较。

Cochrane Database Syst Rev. 2014 Jul 8;2014(7):CD009396. doi: 10.1002/14651858.CD009396.pub2.

Trifluoperazine versus placebo for schizophrenia.三氟拉嗪与安慰剂治疗精神分裂症的对比

Cochrane Database Syst Rev. 2014 Jan 11;2014(1):CD010226. doi: 10.1002/14651858.CD010226.pub2.

The management of schizophrenia in family practice.家庭医学中的精神分裂症管理。

Can Fam Physician. 1984 Feb;30:399-402.

Trifluoperazine for schizophrenia.三氟拉嗪用于治疗精神分裂症。

Cochrane Database Syst Rev. 2004;2004(1):CD003545. doi: 10.1002/14651858.CD003545.pub2.

High dosage haloperidol therapy in chronic schizophrenic patients: a double-blind study of clinical response, side effects, serum haloperidol, and serum prolactin.高剂量氟哌啶醇治疗慢性精神分裂症患者：临床反应、副作用、血清氟哌啶醇及血清催乳素的双盲研究

Psychopharmacology (Berl). 1980 Jan;67(1):17-23. doi: 10.1007/BF00427590.

Chlorpromazine in chronic schizophrenia: behavioral dose-response relationships.氯丙嗪治疗慢性精神分裂症：行为剂量-反应关系

Psychopharmacologia. 1970;18(3):260-70. doi: 10.1007/BF00412672.

Antipsychotic drugs: clinical pharmacology and therapeutic use.抗精神病药物：临床药理学与治疗用途。

Drugs. 1977 Oct;14(4):260-82. doi: 10.2165/00003495-197714040-00002.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验